GMED
Globus Medical Inc Class A · NYSE
- Sector Health Technology
- Industry Medical Specialties
- Website globusmedical.com
- Employees(FY) 2600
- ISIN US3795772082
Performance
-4.4%
1W
-0.04%
1M
-21.51%
3M
-5.17%
6M
-14.15%
YTD
+38.69%
1Y
Profile
Globus Medical, Inc., a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. It offers spine products, such as traditional fusion implants comprising pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devices for treating degenerative and congenital conditions, deformity, tumors, and trauma injuries; treatment options for motion preservation technologies that consist of dynamic stabilization, total disc replacement, and interspinous distraction devices; interventional pain management solutions to treat vertebral compression fractures; and regenerative biologic products comprising of allografts and synthetic alternatives. The company also offers products for the treatment of orthopedic trauma, including fracture plates, compression screws, intramedullary nails, and external fixation systems; and hip and knee joint solutions, including modular hip stems and acetabular cups, as well as posterior stabilizing and cruciate retaining knee arthroplasty implants. In addition, it distributes human cell, tissue, and cellular and tissue-based products. The company sells its products through direct or distributor sales presence, as well as its hip and knee products primarily through independent sales agents. Globus Medical, Inc. was incorporated in 2003 and is headquartered in Audubon, Pennsylvania.
Technical Analysis of GMED 2025-04-17
Technical Scores and Rating
Moving Average Score
Oscillator Score
Technical Rating
Recent News & Updates
- 2025-04-03 17:42
Globus acquires US medical device company Nevro(Yahoo Finance)
- 2025-04-02 20:31
Globus Medical completes acquisition of Nevro Corp.(Globenewswire)
- 2025-03-20 20:22
- 2025-03-18 22:02
- 2025-03-11 04:40
- 2025-03-10 17:04
- 2025-03-06 03:40
- 2025-03-05 06:01
- 2025-03-04 20:13
- 2025-03-04 10:47
- 2025-03-04 03:15
- 2025-03-03 19:06
1 Mid-Cap Stock to Target This Week and 2 to Avoid(Yahoo Finance)
- 2025-02-20 13:15
- 2025-02-20 09:00
Globus Medical (GMED) Q4 2024 Earnings Call Transcript(Yahoo Finance)
- 2025-02-20 06:00
- 2025-02-20 04:55
Globus Medical (GMED) Q4 Earnings and Revenues Top Estimates(Yahoo Finance)
- 2025-02-20 04:04
Globus Medical: Q4 Earnings Snapshot(Yahoo Finance)
- 2025-02-20 03:58
Globus Medicals (NYSE:GMED) Q4 Sales Beat Estimates(Yahoo Finance)
- 2025-02-20 03:15
- 2025-02-18 19:08
Globus Medical (GMED) Q4 Earnings: What To Expect(Yahoo Finance)
- 2025-02-17 10:00
- 2025-02-17 09:16
- 2025-02-13 17:15
- 2025-02-13 10:01
- 2025-02-11 08:14
- 2025-02-10 12:55
Globus Medical strengthens SCS market position with $250m Nevro deal(Medical Device Network)
- 2025-02-07 09:35
- 2025-02-06 13:49
- 2025-02-06 09:57
Globus Medical to Acquire Nevro(MT Newswires)
- 2025-02-06 09:30
Page 1 of 9
previousnext
Disclaimer: The information provided here and on kavout.com is for general informational purposes only. It does not constitute investment advice, financial advice, trading advice, or any other sort of advice. Kavout makes no recommendations regarding investment decisions based on this information. You are solely responsible for your investments. Please conduct your own research and consult qualified financial advisors before investing. Past performance does not guarantee future results.